Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
NCT05582798
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Bronchiectasis Adult
Interventions
DRUG:
Alpha 1-Proteinase Inhibitor 180mg/kg
DRUG:
Alpha 1-Proteinase Inhibitor 120mg/kg
DRUG:
Sodium chloride
Sponsor
University of Dundee